Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07446907 · ClinicalTrials.gov registry record · NA

Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood

A NA study, sponsored by University of Alabama at Birmingham.

Not yet
Registry status
NA
Development phase
250
Enrollment target

NCT07446907: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.

NCT07446907 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07446907, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.

NOT YET RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

To test adaptive intensive behavioral therapy strategies comprising dietary patterns with varying amounts of protein and including supplemental protein or resistance exercise training for promoting weight loss and attenuating lean mass loss in adults aged 50-75 with obesity.

Primary Outcome

Participants will be weighed at baseline through 52 weeks

Interventions

  • BEHAVIORAL Supervised Exercise
  • BEHAVIORAL High Protein Diet Counceling
  • BEHAVIORAL Standard Protein Diet Counceling
  • BEHAVIORAL Protein Supplement

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-07-01
Est. Completion 2031-06-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What is known before NCT07446907 opens enrollment

NCT07446907 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 4 interventions - of which Supervised Exercise is the first listed.

NCT07446907 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07446907 about?

NCT07446907 is a clinical study titled "Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood". To test adaptive intensive behavioral therapy strategies comprising dietary patterns with varying amounts of protein and including supplemental protein or resistance exercise training for promoting weight loss and attenuating lean mass loss in adults aged 50-75 with obesity.

What is the current status of trial NCT07446907?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-07-01. Estimated completion is 2031-06-30.

What interventions are being tested in trial NCT07446907?

The interventions under investigation include: Supervised Exercise (BEHAVIORAL), High Protein Diet Counceling (BEHAVIORAL), Standard Protein Diet Counceling (BEHAVIORAL), Protein Supplement (BEHAVIORAL).

Who is sponsoring clinical trial NCT07446907?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07446907's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07446907, the US trial registry maintained by the National Library of Medicine. NCT07446907 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.